HUMIRA (adalimumab) Hidradenitis Suppurativa Clinical Data
TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis | Nature Communications
View Image
JCM | Free Full-Text | The Optimal Management of Fistulizing Crohn’s Disease: Evidence beyond Randomized Clinical Trials
An extraordinary form of the Melkersson-Rosenthal syndrome successfully treated with the tumour necrosis factor-α blocker adalimumab | BMJ Case Reports
Adalimumab Effective in Pediatric Plaque Psoriasis | RheumNow
Early administration of adalimumab for paediatric uveitis due to Behçet's disease | Pediatric Rheumatology | Full Text
Adalimumab for Refractory Folliculitis Decalvans. — Donovan Hair Clinic
Efficacy of Adalimumab for Nail Psoriasis During 24 Months of Continuous Therapy | HTML | Acta Dermato-Venereologica
Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa* - Cao - 2021 - British Journal of Dermatology - Wiley Online Library
Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody – OS2966 | Scientific Reports
A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis | SpringerLink
AbbVie, Johnson & Johnson Lead US Immunology Drug Market Due to High Cost of Biologic Treatments - iData Research
Overview of Humira® Biosimilars: Current European Landscape and Future Implications - Journal of Pharmaceutical Sciences
Refractory dissecting Cellulitis of the Scalp Successfully controlled with Adalimumab. | Semantic Scholar
Full article: Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease
Early administration of adalimumab for paediatric uveitis due to Behçet's disease | Pediatric Rheumatology | Full Text
PHARMACY POLICY STATEMENT
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial - The Lancet
Overview of Humira® Biosimilars: Current European Landscape and Future Implications - Journal of Pharmaceutical Sciences
Phototherapy remains a valuable psoriasis treatment
Frontiers | Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Clinical findings of the patient. (A) Erythematous scaly papules and... | Download Scientific Diagram
Excimer Laser Therapy for Hairline Psoriasis: A Useful Addition to the Scalp Psoriasis Treatment Algorithm
Chronic verrucous sarcoidosis associated with human papillomavirus infection: Improvement with adalimumab | Semantic Scholar
Treatment of Hidradenitis Suppurativa in 2021 & Beyond - Next Steps in Dermatology
